Table 2.
Incidence of CLAB, CAUTI, VAP, and mortality during the two study periods
| Open infusion container N = 548 |
Closed infusion container N = 548 |
RR | 95% CI | P-value | |
|---|---|---|---|---|---|
| CL days no. | 3661 | 4055 | - | - | - |
| CLAB no. | 59 | 13 | - | - | - |
| CLAB per 1000 CL days | 16.1 | 3.2 | 0.20 | 0.11 - 0.36 | <0.01 |
| Percentage of patients with CLAB | 10.8 | 2.4 | 0.22 | 0.12 - 0.40 | <0.01 |
| Urinary catheter days no. | 3302 | 3590 | - | - | - |
| CAUTI no. | 30 | 36 | - | - | - |
| CAUTI per 1000 catheter days | 9.1 | 10.0 | 1.10 | 0.68 - 1.79 | 0.69 |
| Mechanical ventilator days no. | 2344 | 2592 | - | - | - |
| VAP no. | 66 | 71 | - | - | - |
| VAP per 1000 mechanical ventilator days | 28.2 | 27.4 | 0.97 | 0.70 - 1.35 | 0.87 |
| Deaths no. | 128 | 88 | - | - | - |
| Percentage of patients who died | 23.4 | 16.1 | 0.69 | 0.54 - 0.88 | <0.01 |
no., number; CL, central line; CLAB, central line-associated bloodstream infection; CAUTI, catheter-associated urinary tract infection; VAP, ventilator-associated pneumonia